7.05
price down icon5.24%   -0.39
 
loading
Passage Bio Inc stock is traded at $7.05, with a volume of 51,320. It is down -5.24% in the last 24 hours and up +2,029% over the past month. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
See More
Previous Close:
$7.44
Open:
$7.44
24h Volume:
51,320
Relative Volume:
0.15
Market Cap:
$22.00M
Revenue:
-
Net Income/Loss:
$-68.80M
P/E Ratio:
-6.0256
EPS:
-1.17
Net Cash Flow:
$-59.06M
1W Performance:
+33.78%
1M Performance:
+2,029%
6M Performance:
+1,123%
1Y Performance:
+668.81%
1-Day Range:
Value
$6.86
$7.566
1-Week Range:
Value
$5.32
$7.6996
52-Week Range:
Value
$0.257
$7.6996

Passage Bio Inc Stock (PASG) Company Profile

Name
Name
Passage Bio Inc
Name
Phone
(267) 866-0312
Name
Address
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Name
Employee
60
Name
Twitter
@passage_bio
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
PASG's Discussions on Twitter

Compare PASG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PASG
Passage Bio Inc
7.05 23.21M 0 -68.80M -59.06M -1.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Passage Bio Inc Stock (PASG) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-29-24 Resumed Wedbush Outperform
Sep-03-24 Initiated Rodman & Renshaw Buy
Mar-08-22 Downgrade JP Morgan Overweight → Neutral
Jan-19-22 Downgrade Goldman Buy → Neutral
Jul-01-21 Initiated Raymond James Outperform
Jun-15-21 Initiated BTIG Research Buy
Mar-04-21 Upgrade Goldman Neutral → Buy
Feb-04-21 Initiated Guggenheim Buy
Jan-25-21 Initiated Wedbush Outperform
Jan-04-21 Upgrade JP Morgan Neutral → Overweight
Dec-11-20 Initiated Citigroup Neutral
Aug-14-20 Downgrade JP Morgan Overweight → Neutral
Jun-25-20 Downgrade Goldman Buy → Neutral
Mar-25-20 Initiated Chardan Capital Markets Buy
Mar-24-20 Initiated Cowen Outperform
Mar-24-20 Initiated Goldman Buy
Mar-24-20 Initiated JP Morgan Overweight
View All

Passage Bio Inc Stock (PASG) Latest News

pulisher
Jul 28, 2025

How strong is Passage Bio Inc. company’s balance sheetRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Historical volatility pattern of Passage Bio Inc. visualizedFree Investment Playbook for Growing Markets - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What machine learning models say about Passage Bio Inc.Forecasting Stock Moves with AI Insights - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Real time social sentiment graph for Passage Bio Inc.Daily Market Movers Screener with Filters - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What moving averages say about Passage Bio Inc. Weekly Breakout Forecast with Entry Zones - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What machine learning models say about Passage Bio Inc. Accurate Forecast System with AI Support - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Does Passage Bio Inc. stock perform well during market downturnsExplosive trading opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Passage Bio Inc. stockBreakout stock performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are Passage Bio Inc. company’s key revenue driversBuild a diversified portfolio for risk management - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Passage Bio Inc.Superior trading gains - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Passage Bio Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What analysts say about Passage Bio Inc. stock outlookReliable High Profit Alerts - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Will Passage Bio Inc. Stock Benefit from AI and Green Energy TrendsFree Stock Market Expert Consultation - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Is Passage Bio Inc. Stock a Good Fit for Conservative InvestorsRisk Controlled Trading Ideas - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why Passage Bio Inc. stock attracts strong analyst attentionFree Discussion Group - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Passage Bio Skyrockets 31.04%—Is Institutional Buying the Catalyst for a Biotech Breakout? - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Passage Bio Inc. stockFree Trading Psychology Coaching - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Passage Bio Soars 12.39% on Institutional Buying Spree - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Passage Bio Inc. stock priceAccelerated financial growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Passage Bio Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will Passage Bio Inc. stock benefit from interest rate changesAccelerated earnings growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What makes Passage Bio Inc. stock price move sharplyStable Growth Stock Picks - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

Lynx1 capital buys Passage Bio (PASG) shares worth $733,825 - Investing.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Passage Bio Inc. a good long term investmentFree Stock Movement Tracking - jammulinksnews.com

Jul 23, 2025

Passage Bio Inc Stock (PASG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Cap:     |  Volume (24h):